Connecting the Dots in Early Drug Discovery at Novartis
Discover how Novartis connects vast amounts of heterogeneous data using graph technology to conduct drug discovery and achieve scalable biological knowledge.
Connecting the dots in early drug discovery at Novartis Skip to content Neo4j to acquire GraphAware, launch new open-standards intelligence analysis solutions | Read more Menu Search Close Menu Products FULLY-MANAGED AuraDB Store and query connected data at scale Virtual Graph Create and query a knowledge graph on existing data Aura Graph Analytics Run graph algorithms on any data, any cloud Aura Agent Build and deploy context-aware agents fast SELF-MANAGED Graph Database Store connected data with a graph database Graph Data Science Run graph algorithms on connected data Enterprise Studio Secu
related reading
- Building a graph to map gene variants w/ Neo4j: GeneWeaverneo4j.com
- A Gentle Introduction to Graph Neural Networksdistill.pub
- What are graph algorithms? A comprehensive guideneo4j.com
- From good to graph: Choosing the right databaseneo4j.com
- Full-text search in 197M chemical names graph databaseneo4j.com
- The Business of Extracting Knowledge from Academic Publicationsmarkusstrasser.org
- TorchDrug: A Powerful and Flexible Machine Learning Platform for Drug Discoveryarxiv.org
- Graph database blockchain: How to import Bitcoin blockchain into Neo4jneo4j.com
- Knowledge graph vs. vector database for grounding your LLMneo4j.com
- Paving the way for agents in biology \ Anthropicanthropic.com
- The GraphRAG manifesto: Adding knowledge to GenAIneo4j.com
- An experimentally validated approach to automated biological evidence generation in drug discovery using knowledge graphs | Nature Communicationsnature.com